Silo Pharma, Inc. financial data

Symbol
SILO on Nasdaq
Industry
Pharmaceutical Preparations
Location
677 N. Washington Blvd, Sarasota, FL
State of incorporation
NV
Fiscal year end
December 31
Former names
Uppercut Brands, Inc. (to 8/14/2020), Point Capital, Inc. (to 5/14/2019), Gold Swap Inc (to 1/7/2013)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 612 % -46.4%
Debt-to-equity 34.2 % +63.1%
Return On Assets -56.8 % -45.7%
Operating Margin -6.53K % -22%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.48M shares +57.7%
Common Stock, Shares, Outstanding 4.48M shares +54.3%
Entity Public Float 3.43M USD -42.5%
Common Stock, Value, Issued 449 USD +42.1%
Weighted Average Number of Shares Outstanding, Basic 3.68M shares +19.5%
Weighted Average Number of Shares Outstanding, Diluted 3.68M shares +19.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 72.1K USD 0%
Cost of Revenue 5.84K USD 0%
Research and Development Expense 2.37M USD +180%
Operating Income (Loss) -4.71M USD -22%
Nonoperating Income (Expense) 313K USD +39.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.39M USD -21%
Income Tax Expense (Benefit) 906K USD +50.3%
Net Income (Loss) Attributable to Parent -4.39M USD -18.7%
Earnings Per Share, Basic -1.19 USD/shares +0.83%
Earnings Per Share, Diluted -1.19 USD/shares +0.83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.91M USD +10.8%
Assets, Current 7.11M USD -7.42%
Intangible Assets, Net (Excluding Goodwill) 241K USD
Assets 7.41M USD -4.32%
Accounts Payable, Current 144K USD
Contract with Customer, Liability, Current 72.1K USD 0%
Liabilities, Current 1.66M USD +114%
Contract with Customer, Liability, Noncurrent 722K USD -9.09%
Liabilities 2.38M USD +51.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.42K USD
Retained Earnings (Accumulated Deficit) -15.3M USD -40.4%
Stockholders' Equity Attributable to Parent 5.03M USD -18.5%
Liabilities and Equity 7.41M USD -4.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -838K USD -21%
Net Cash Provided by (Used in) Financing Activities -115K USD
Net Cash Provided by (Used in) Investing Activities 97.6K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.48M shares +42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.91M USD +10.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.87K USD -98.9%
Deferred Tax Assets, Valuation Allowance 3.71M USD +46.2%
Deferred Tax Assets, Gross 3.71M USD +46.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.38M USD -18.3%
Lessee, Operating Lease, Liability, to be Paid 1.88M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.88M USD
Deferred Tax Assets, Operating Loss Carryforwards 2.96M USD +25.6%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 20.3M USD +15.8%
Deferred Tax Assets, Net of Valuation Allowance 2.54M USD +63.7%
Interest Expense 5.08K USD +13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%